Dronedarone for atrial fibrillation--an odyssey.
Zimetbaum
Peter J
PJ
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA.
D026683:Advisory Committees; D000638:Amiodarone / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000401:mortality; D001282:Atrial Flutter / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D000077764:Dronedarone; D017277:Drug Approval; D006801:Humans; D015394:Molecular Structure; D013318:Stroke Volume; D014481:United States; D014486:United States Food and Drug Administration
D000889:Anti-Arrhythmia Agents; D000077764:Dronedarone; D000638:Amiodarone